Erratum: Stimulation of GPR30 Increases Release of EMMPRIN-Containing Microvesicles in Human Uterine Epithelial Cells (Journal of Clinical Endocrinology and Metabolism (2012) 97 (4613-4622) DOI:10.1210/jc.2012-2098);Stimulation of GPR30 increases release of EMMPRIN-containing microvesicles in human uterine epithelial cells

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4613-4622

  Burnett, Lindsey A ^a   Light, Mallory M ^a   Mehrotra, Pavni ^a   Nowak, Romana A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; CHOLERA TOXIN; ESTRADIOL; G PROTEIN COUPLED RECEPTOR 30;

ARTICLE; CELL ISOLATION; CELL LINE; CELL VACUOLE; CONTROLLED STUDY; ENDOMETRIUM; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MICROVESICLE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; RNA EXTRACTION; UTERINE EPITHELIAL CELL; WESTERN BLOTTING;

EID: 84870751149     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3586     Document Type: Erratum

References (42)

1. Edwards DP 2005 Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol 67:335-376 (Pubitemid 40409510)
2. Lange CA 2008 Challenges to defining a role for progesterone in breast cancer. Steroids 73:914-921
3. Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S 2005 EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie (Paris) 87:361-368 (Pubitemid 40387615)
4. Millimaggi D, Mari M, D'Ascenzo S, Carosa E, Jannini EA, Zucker S, Carta G, Pavan A, Dolo V 2007 Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 9:349-357 (Pubitemid 46608302)
5. Alcazar O, Hawkridge AM, Collier TS, Cousins SW, Bhattacharya SK, Muddiman DC, Marin-Castano ME 2009 Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells. Mol Cell Proteomics 8:2201-2211
6. Sillanpää S, Anttila M, Suhonen K, Hämäläinen K, Turpeenniemi- Hujanen T, Puistola U, Tammi M, Sironen R, Saarikoski S, Kosma VM 2007 Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer. Tumour Biol 28:280-289
7. Wu Y, Zhou X, Zheng PS 2011 Involvement of CD147 isoform4 in the proliferation of SiHa cells: a possible molecular mechanism of cervical cancer. Oncol Rep 26:717-724
8. Braundmeier AG, Fazleabas AT, Lessey BA, Guo H, Toole BP, Nowak RA 2006 Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium. J Clin Endocrinol Metab 91:2358-2365 (Pubitemid 43855028)
9. Noguchi Y, Sato T, Hirata M, Hara T, Ohama K, Ito A 2003 Identification and characterization of extracellular matrix metalloproteinase inducer in human endometrium during the menstrual cycle in vivo and in vitro. J Clin Endocrinol Metab 88:6063-6072 (Pubitemid 38033094)
10. Pedram A, Razandi M, Levin ER 2006 Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20: 1996-2009 (Pubitemid 44286700)
11. Levin ER 2005 Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 19:1951-1959 (Pubitemid 41124194)
12. Harrington WR, Kim SH, Funk CC, Madak-Erdogan Z, Schiff R, Katzenellenbogen JA, Katzenellenbogen BS 2006 Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol 20:491-502 (Pubitemid 43291204)
13. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630 (Pubitemid 40354745)
14. Filardo EJ, Quinn JA, Frackelton Jr AR, Bland KI 2002 Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70-84 (Pubitemid 34044499)
15. Hombach-Klonisch S, Kehlen A, Fowler PA, Huppertz B, Jugert JF, Bischoff G, Schlüter E, Buchmann J, Klonisch T 2005 Regulation of functional steroid receptors and ligand-induced responses in telomerase- immortalized human endometrial epithelial cells. Journal of molecular endocrinology 34:517-534 (Pubitemid 40585199)
16. Braundmeier AG, Nowak RA 2006 Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. Am J Reprod Immunol 56:201-214 (Pubitemid 44151494)
17. Redzic JS, Armstrong GS, Isern NG, Jones DN, Kieft JS, Eisenmesser EZ 2011 The retinal specific CD147 Ig0 domain: from molecular structure to biological activity. J Mol Biol 411:68-82
18. Atay S, Gercel-Taylor C, Kesimer M, Taylor DD 2011 Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells. Exp Cell Res 317:1192-1202
19. Otto C, Fuchs I, Kauselmann G, Kern H, Zevnik B, Andreasen P, Schwarz G, Altmann H, Klewer M, Schoor M, Vonk R, Fritzemeier KH 2009 GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol Reprod 80:34-41
20. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Andó S, Maggiolini M 2006 17 ß-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol 70:1414-1423 (Pubitemid 44435994)
21. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andó S, Maggiolini M 2006 The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17ß-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 20:631-646 (Pubitemid 43291214)
22. Lin BC, Suzawa M, Blind RD, Tobias SC, Bulun SE, Scanlan TS, Ingraham HA 2009 Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res 69:5415-5423
23. Smith HO,Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE, Prossnitz ER 2007 GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 196:386.e1-e9; discussion 386.e9-e11
24. Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, Steinhoff MM, Sabo E 2006 Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 12:6359-6366 (Pubitemid 44799705)
25. Filardo EJ, Quinn JA, Bland KI, Frackelton Jr AR 2000 Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649-1660
26. Carmeci C, Thompson DA, Ring HZ, Francke U, Weigel RJ 1997 Identification of a gene (GPR30) with homology to the G-proteincoupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45:607-617 (Pubitemid 27506136)
27. Albanito L, Sisci D, Aquila S, Brunelli E, Vivacqua A, Madeo A, Lappano R, Pandey DP, Picard D, Mauro L, Andó S, Maggiolini M 2008 Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. Endocrinology 149:3799-3808
28. Wang D, Hu L, Zhang G, Zhang L, ChenC2010Gprotein-coupled receptor 30 in tumor development. Endocrine 38:29-37
29. He YY, Cai B, Yang YX, Liu XL, Wan XP 2009 Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogenactivated protein kinase pathway. Cancer Sci 100:1051-1061
30. Leblanc K, Sexton E, Parent S, Bélanger G, Déry MC, Boucher V, Asselin E 2007 Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens. Int J Oncol 30:477-487
31. Soloff MS, Szego CM 1969 Purification of estradiol receptor from rat uterus and blockade of its estrogen-binding function by specific antibody. Biochem Biophys Res Commun 34:141-147
32. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andó S, Maggiolini M 2007 G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17ß-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67:1859-1866 (Pubitemid 46383413)
33. Henic E, Noskova V, Hoyer-Hansen G, Hansson S, Casslen B 2009 Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells. Int J Gynecol Cancer 19:214-222
34. Chan QK, Lam HM, Ng CF, Lee AY, Chan ES, Ng HK, Ho SM, Lau KM 2010 Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrest. Cell Death Differ 17:1511-1523
35. Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER 2009 GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol 114:465-471
36. Sidhu SS, Mengistab AT, Tauscher AN, LaVail J, Basbaum C 2004 The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 23:956-963 (Pubitemid 38250941)
37. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V 2002 Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160:673-680 (Pubitemid 34160345)
38. Wei Y, Zhang Z, Liao H, Wu L, Wu X, Zhou D, Xi X, Zhu Y, Feng Y 2012 Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation. Oncol Rep 27:504-510
39. Gao F, Ma X, Ostmann AB, Das SK 2011 GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor α (ERα) phosphorylation signals. Endocrinology 152:1434-1447
40. Prossnitz ER, Barton M 2011 The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 7:715-726
41. Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, Picard D 2009 Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J 28:523-532
42. Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG, Oprea TI, Yamaguchi Y, Hayashi S, Sklar LA, Hathaway HJ, Arterburn JB, Prossnitz ER 2011 Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J Steroid Biochem Mol Biol 127:358-366